Perretti M, Solito E, Parente L
Sclavo Research Centre, Laboratory of Pharmacology, Siena, Italy.
Agents Actions. 1992 Jan;35(1-2):71-8. doi: 10.1007/BF01990954.
As a putative mediator of inflammation interleukin-1 has been implicated in the recruitment of leukocytes during the early stages of the inflammatory reaction. In the present report we have investigated the release of endogenous IL-1 in the rat zymosan pleurisy and in the mouse zymosan peritonitis. In both cases the release of the cytokine was maximal 4 hours after zymosan injection and appeared to be time-related to neutrophil migration into the inflammatory site. The effect of in vivo treatment with dexamethasone in rat pleurisy and with polyclonal anti-murine IL-1 beta antibody in mouse peritonitis was also assessed. The steroid reduced both cell migration and the release of IL-1-like activity as well as the formation of exudate and the release of eicosanoids. The anti-IL-1 beta serum inhibited selectively the number of neutrophil that migrated to the inflamed site (approximately 40%) and the IL-1 activity recovered in (approximately 70%) the exudate. In vitro incubation of the inflammatory exudate with polyclonal anti-murine IL-1 alpha or anti-murine IL-1 beta sera allowed the identification of the IL-1 species present. In the rat pleurisy IL-1 biological activity was mainly due to the alpha species, whereas IL-1 beta was the only species apparently present in the mouse peritoneal exudate.
作为一种假定的炎症介质,白细胞介素-1在炎症反应早期参与白细胞的募集。在本报告中,我们研究了大鼠酵母聚糖性胸膜炎和小鼠酵母聚糖性腹膜炎中内源性白细胞介素-1的释放情况。在这两种情况下,细胞因子的释放在酵母聚糖注射后4小时达到最大值,并且似乎与中性粒细胞向炎症部位的迁移在时间上相关。我们还评估了在大鼠胸膜炎中用 dexamethasone 进行体内治疗以及在小鼠腹膜炎中用多克隆抗小鼠白细胞介素-1β 抗体进行体内治疗的效果。该类固醇减少了细胞迁移以及白细胞介素-1样活性的释放,同时减少了渗出液的形成和类花生酸的释放。抗白细胞介素-1β 血清选择性地抑制了迁移到炎症部位的中性粒细胞数量(约40%)以及在渗出液中恢复的白细胞介素-1活性(约70%)。用多克隆抗小鼠白细胞介素-1α 或抗小鼠白细胞介素-1β 血清对炎症渗出液进行体外孵育,从而能够鉴定出存在的白细胞介素-1种类。在大鼠胸膜炎中,白细胞介素-1的生物活性主要归因于α 种类,而白细胞介素-1β 显然是小鼠腹腔渗出液中唯一存在的种类。